Biosimilars

COVID-19

Cataract Surgery

Cataract

Cataract Therapeutics

Clinical Diagnosis

Cornea

Dry Eye Awareness

Dry Eye

Gene Therapy

Geographic Atrophy

Glaucoma Awareness

Glaucoma Insights

Therapeutic Glaucoma

Glaucoma

IOL Advances

Imaging

Ocular Allergy

Ocular Surface Disease

Optic Relief

Optometry

Pediatrics

Pharmacy

Indispensable

Practice Management

Presbyopia

Ptosis

Refractive Surgery

Refractive

Retina

Surgery

Technology

Therapeutics

Understanding Antibiotic Resistance

Workplace

News

All News

Contributors

Money Matters

Media

Expert Interviews

Medical World News

Podcasts

Case Based Roundtable Series

Case of the Quarter

EyeView

Grand Rounds

Insights

Rapid Readout

Viewpoints

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Events

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Partners

Subscribe

Resources

Job Board

About

Advertise

Privacy

Editorial

Terms and Conditions

Contact Us

Do Not Sell My Personal Information

Ophthalmology Times - Ophthalmology news, articles, and events

Facebook

Twitter

Instagram

LinkedIn

Spotlight

Clinical

View

The Role of Miotic Agents in the Management of Presbyopia

Videos

Eyecare professionals examine the emerging role of miotic agents as promising treatment options for the management of patients with presbyopia.

Francis S. Mah, MD, and Andrew S. Morgenstern, OD, FAAO, FNAP, review the impact of presbyopia on quality of life as well as current treatment options and unmet needs for disease management.

Overview of Presbyopia

Drs Andrew S. Morgenstern and Francis S. Mah provide insight on the functionality of ocular accommodation as an autofocus lens and how this is affected in patients with presbyopia.

Impact of Presbyopia on Mechanism of Ocular Accommodation

Francis S. Mah, MD, reviews miotic agents that are available or under investigation for the treatment of presbyopia.

Miotic Treatment Options for Presbyopia

Andrew S. Morgenstern discusses the selectivity of miotic agents in isolating the pupil while limiting adverse events for the management of presbyopia.

Miotic Selectivity in the Management of Presbyopia

Andrew S. Morgenstern, OD, FAAO, FNAP, highlights the importance of reducing pupil size to a certain level to optimize near vision for patients with presbyopia.

ICYMI: Targeting Pupil Size for Presbyopia Management

Expert eye care specialists discuss the role of miotic agents in targeting presbyopia in patients.

ICYMI: Using Miotic Agents for the Management of Presbyopia

Expert eye care specialists comment on the use of aceclidine as a selective miotic for the treatment of presbyopia.

Role of Aceclidine in Presbyopia Treatment

The Ophthalmology Times® Viewpoints program facilitates roundtable discussions with experts of the ophthalmic community to explore a variety of disease focused topics. Areas of discussion include diagnosis & treatment, patient journey, treatment planning, treatment options, and genetic testing.

Overview of Presbyopia

EP: 1.Overview of Presbyopia

EP: 2.Impact of Presbyopia on Mechanism of Ocular Accommodation

EP: 3.Miotic Treatment Options for Presbyopia

EP: 4.Miotic Selectivity in the Management of Presbyopia

EP: 5.ICYMI: Targeting Pupil Size for Presbyopia Management

EP: 6.ICYMI: Using Miotic Agents for the Management of Presbyopia

EP: 7.Role of Aceclidine in Presbyopia Treatment